Saing, John Crisler Jay B.

HRN: 28-21-88  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
CEFTRIAXONE 1G (VIAL)
12/06/2025
12/13/2025
IV
2g
Q24 Anst
Open Fracture
Checking Final Appropriateness 
12/12/2025
CO-AMOXICLAV 625MG (TAB)
12/12/2025
12/18/2025
IV
625mg
Q8
Open Patellar Fracture Post Op
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: